Patent Assignment
Reel/Frame 075472/0569
Change of Name
Recorded: 2026-04-23
Pages: 4
Assignor
SAGE THERAPEUTICS, INC.
Executed: 2025-08-20
Assignee
SAGE THERAPEUTICS, LLC
9715 KEY WEST AVENUE, ROCKVILLE, MARYLAND, 20850
Covered Properties
(50)
Crystalline Forms of a Neuroactive Steroid
Application:
18/893,012 →
Publication:
US US20250243237A1
Crystalline Forms of a Neuroactive Steroid
Application:
18/997,582 →
Deuterated Neuroactive Steroids
Application:
19/111,449 →
Neuroactive Steroids and Their Methods of Use
Neuroactive Steroids and Compositions Thereof
Application:
18/003,215 →
Publication:
US US20230250129A1
Compositions and Methods for Treating Cns Disorders
Application:
19/234,399 →
Publication:
US US20260098053A1
Compositions and Methods for Treating Cns Disorders
Application:
17/620,303 →
Publication:
US US20230085354A1
Compositions and Methods for Treating Cns Disorders
Application:
18/254,209 →
Publication:
US US20240101592A1
Compounds for Treating Cns Disorders
Application:
18/473,702 →
Publication:
US US20240300996A1
Neuroactive Steroids and Compositions Thereof
Application:
19/064,318 →
Publication:
US US20250250296A1
Neuroactive Steroids and Compositions Thereof
Application:
19/176,652 →
Publication:
US US20250236639A1
Neuroactive Steroids and Their Methods of Use
Application:
19/019,743 →
Publication:
US US20250154194A1
Compositions and Methods for Treating Cns Disorders
Application:
19/291,992 →
Publication:
US US20260078143A1
Compositions and Methods for Treating Cns Disorders
Application:
16/955,714 →
Publication:
US US20210101928A1
9(11)-Unsaturated Neuroactive Steroids and Their Methods of Use
Application:
18/940,062 →
Publication:
US US20250136638A1
Neuroactive Steroids Substituted in Position 10 with a Cyclic Group for Use in the Treatment of Cns Disorders
C7, C12, and C16 Substituted Neuroactive Steroids and Their Methods of Use
Application:
18/636,563 →
Publication:
US US20250092084A1
Compositions and Methods for Treating Cns Disorders
Application:
18/771,262 →
Publication:
US US20250171492A1
Compositions and Methods for Treating Cns Disorders
Application:
18/947,793 →
Publication:
US US20250236638A1
Compositions and Methods for Treating Cns Disorders
Application:
18/741,425 →
Publication:
US US20240368213A1
Neuroactive Steroids, Compositions, and Uses Thereof
Neuroactive Steroids, Compositions, and Uses Thereof
19-Nor Neuroactive Steroids and Methods of Use Thereof
19-Nor Neuroactive Steroids and Methods of Use Thereof
19-Nor Neuroactive Steroids and Methods of Use Thereof
19-Nor C3, 3-Disubstituted C21-C-Bound Heteroaryl Steroids and Methods of Use Thereof
Patent:
10,391,106 →
Application:
15/639,702 →
19-Nor C3, 3-Disubstituted C21-C-Bound Heteroaryl Steroids and Methods of Use Thereof
19-Nor C3, 3-Disubstituted C21-C-Bound Heteroaryl Steroids and Methods of Use Thereof
Neuroactive Steroids, Compositions, and Uses Thereof
Neuroactive Steroids, Compositions, and Uses Thereof
Compositions and Methods for Treating Cns Disorders
Compositions and Methods for Treating Cns Disorders
Compositions and Methods for Treating Cns Disorders
Compositions and Methods for Treating Cns Disorders
Compositions and Methods for Treating Cns Disorders
Compositions and Methods for Treating Cns Disorders
C7, C12, and C16 Substituted Neuroactive Steroids and Their Methods of Use
Compositions and Methods for Treating Cns Disorders
Compositions and Methods for Treating Cns Disorders
Neuroactive Steroids Substituted in Position 10 with a Cyclic Group for Use in the Treatment of Cns Disorders
Neuroactive Steroids and Their Methods of Use
Neuroactive Steroids and Their Methods of Use
Neuroactive Steroids and Their Methods of Use
Neuroactive Steroids and Their Methods of Use
Neuroactive Steroids and Their Methods of Use
Neuroactive Steroids and Their Methods of Use
Neuroactive Steroids and Compositions Thereof
Compositions and Methods for Treating Cns Disorders
Crystalline Forms of a Neuroactive Steroid
Crystalline Forms of a Neuroactive Steroid
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 7, 2016
From: MARTINEZ BOTELLA, GABRIEL; HARRISON, BOYD L.; ROBICHAUD, ALBERT JEAN; SALITURO, FRANCESCO G.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 039963/0768 →
Assignment of Assignor's Interest
Apr 18, 2019
From: MARTINEZ BOTELLA, GABRIEL; HARRISON, BOYD L.; ROBICHAUD, ALBERT JEAN; SALITURO, FRANCESCO G.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 048926/0972 →
Assignment of Assignor's Interest
May 7, 2021
From: BOTELLA, GABRIEL MARTINEZ; HARRISON, BOYD L.; ROBICHAUD, ALBERT JEAN; SALITURO, FRANCESCO G.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 056173/0506 →
Assignment of Assignor's Interest
Sep 27, 2021
From: ROBICHAUD, ALBERT JEAN; SALITURO, FRANCESCO G.; BLANCO-PILLADO, MARIA JESUS; LA, DANIEL
To: SAGE THERAPEUTICS, INC.
Reel/Frame 057609/0462 →
Assignment of Assignor's Interest
Feb 10, 2022
From: BOTELLA, GABRIEL MARTINEZ; HARRISON, BOYD L.; ROBICHAUD, ALBERT JEAN; SALITURO, FRANCESCO G.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 058973/0950 →
Assignment of Assignor's Interest
Dec 5, 2022
From: SALITURO, FRANCESCO G.; MORNINGSTAR, MARSHALL LEE; BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 061978/0242 →
Assignment of Assignor's Interest
Mar 16, 2023
From: BLANCO-PILLADO, MARIA JESUS; SALITURO, FRANCESCO G.; MORNINGSTAR, MARSHALL LEE
To: SAGE THERAPEUTICS, INC.
Reel/Frame 062998/0548 →
Assignment of Assignor's Interest
May 11, 2023
From: ROBICHAUD, ALBERT JEAN; SALITURO, FRANCESCO G.; BLANCO-PILLADO, MARIA JESUS; LA, DANIEL
To: SAGE THERAPEUTICS, INC.
Reel/Frame 063613/0408 →
Assignment of Assignor's Interest
May 18, 2023
From: HAN, BINGSONG; BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 063680/0235 →
Assignment of Assignor's Interest
Sep 25, 2023
From: BLANCO-PILLADO, MARIA JESUS; SALITURO, FRANCESCO G.; MORNINGSTAR, MARSHALL LEE
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065011/0884 →
Assignment of Assignor's Interest
Oct 19, 2023
From: BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065279/0778 →
Assignment of Assignor's Interest
Oct 19, 2023
From: BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065279/0556 →
Assignment of Assignor's Interest
Oct 19, 2023
From: BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065279/0846 →
Assignment of Assignor's Interest
Oct 19, 2023
From: BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065279/0637 →
Assignment of Assignor's Interest
Oct 19, 2023
From: BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065279/0394 →
Assignment of Assignor's Interest
Oct 19, 2023
From: BLANCO-PILLADO, MARIA JESUS
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065279/0504 →
Assignment of Assignor's Interest
Jun 21, 2024
From: MARTINEZ BOTELLA, GABRIEL; SALITURO, FRANCESCO G.; ROBICHAUD, ALBERT JEAN; HARRISON, BOYD L.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 067801/0595 →
Assignment of Assignor's Interest
Jun 22, 2024
From: ROBICHAUD, ALBERT JEAN; MARTINEZ BOTELLA, GABRIEL; HARRISON, BOYD L.; SALITURO, FRANCESCO G.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 067808/0186 →
Assignment of Assignor's Interest
Jan 15, 2025
From: SALITURO, FRANCESCO G.; BLANCO-PILLADO, MARIA JESUS; MORNINGSTAR, MARSHALL LEE; HARRISON, BOYD L.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 069882/0926 →
Assignment of Assignor's Interest
Jan 16, 2025
From: ROBICHAUD, ALBERT JEAN; SALITURO, FRANCESCO G.; BLANCO-PILLADO, MARIA JESUS; LA, DANIEL
To: SAGE THERAPEUTICS, INC.
Reel/Frame 069891/0671 →
Assignment of Assignor's Interest
Feb 19, 2025
From: KUANG, SHANMING; LI, TIANRUI
To: SAGE THERAPEUTICS, INC.
Reel/Frame 070255/0507 →
Assignment of Assignor's Interest
Feb 19, 2025
From: BLANCO-PILLADO, MARIA JESUS; SALITURO, FRANCESCO G.; MORNINGSTAR, MARSHALL LEE
To: SAGE THERAPEUTICS, INC.
Reel/Frame 070255/0358 →
Assignment of Assignor's Interest
Feb 19, 2025
From: MARTINEZ BOTELLA, GABRIEL; SALITURO, FRANCESCO G.; ROBICHAUD, ALBERT JEAN; HARRISON, BOYD L.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 070255/0264 →
Assignment of Assignor's Interest
Mar 4, 2025
From: SALITURO, FRANCESCO G.; BLANCO-PILLADO, MARIA JESUS; MORNINGSTAR, MARSHALL LEE
To: SAGE THERAPEUTICS, INC.
Reel/Frame 070394/0464 →
Assignment of Assignor's Interest
Mar 14, 2025
From: HILL, MATTHEW
To: SAGE THERAPEUTICS, INC.
Reel/Frame 070512/0459 →